Cargando…

What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis

BACKGROUND AND AIM: Trials of treatments for non-alcoholic steatohepatitis require endpoint assessment with liver biopsies. Previous large-scale trials have calculated their sample size expecting high retention but on average did not achieve this. We aimed to quantify the proportion of participants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koutoukidis, Dimitrios A., Morris, Elizabeth, Henry, John A., Shammoon, Yusra, Zimmerman, Matthew, Michalopoulou, Moscho, Jebb, Susan A., Aveyard, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059856/ https://www.ncbi.nlm.nih.gov/pubmed/33882107 http://dx.doi.org/10.1371/journal.pone.0250385

Ejemplares similares

Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial
por: Koutoukidis, Dimitrios A, et al.
Publicado: (2017)

Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life
por: Heath, Laura, et al.
Publicado: (2022)

Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
por: Koutoukidis, Dimitrios A., et al.
Publicado: (2019)

The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis
por: Koutoukidis, Dimitrios A, et al.
Publicado: (2022)

Identifying effective characteristics of behavioral weight management interventions for people with serious mental illness: A systematic review with a qualitative comparative analysis
por: Lee, Charlotte, et al.
Publicado: (2021)

Identifying and measuring the behavioural, dietary, and physical activity components of weight management consultations delivered by general practice nurses in routine care
por: Tong, Heather, et al.
Publicado: (2021)

Development and testing of a reduced carbohydrate intervention for the management of obesity and reduction of gestational diabetes (RECORD): protocol for a feasibility randomised controlled trial
por: Michalopoulou, Moscho, et al.
Publicado: (2022)

Prevention in practice: why is it neglected and what can we do?
por: Aveyard, Paul, et al.
Publicado: (2022)

Prominent positioning and food swaps are effective interventions to reduce the saturated fat content of the shopping basket in an experimental online supermarket: a randomized controlled trial
por: Koutoukidis, Dimitrios A., et al.
Publicado: (2019)

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
por: dos Santos, João Paulo Margiotti, et al.
Publicado: (2022)

Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis
por: Spahr, Laurent, et al.
Publicado: (2011)

Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
por: Angelini, Giulia, et al.
Publicado: (2023)

The Association Between Goal Setting and Weight Loss: Prospective Analysis of a Community Weight Loss Program
por: Wren, Gina M, et al.
Publicado: (2023)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
por: Lee, Kyoungbun, et al.
Publicado: (2020)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Evaluation of Liver Biopsy Findings and Comparison with Noninvasive Fibrosis Scores in Patients with Non-Alcoholic Steatohepatitis
por: Biberci Keskin, Elmas, et al.
Publicado: (2019)

Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
por: Wessels, David Hermanus, et al.
Publicado: (2021)

The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients
por: Kenger, Emre Batuhan, et al.
Publicado: (2020)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

What Proportion of Dyspeptic Patients Having H. Pylori Breath Test Subsequently Undergo Endoscopy?
por: Besherdas, Kalpesh, et al.
Publicado: (2000)

‘Willpower’ is not enough: time for a new approach to public health policy to prevent obesity
por: Jebb, Susan A., et al.
Publicado: (2023)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Weight change among people randomized to minimal intervention control groups in weight loss trials
por: Johns, David J., et al.
Publicado: (2016)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2023)

Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients
por: Murakami, Eisuke, et al.
Publicado: (2021)

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
por: Ramalho, F. N., et al.
Publicado: (2017)

Endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Onal, Ibrahim Koral
Publicado: (2014)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Conophylline inhibits non-alcoholic steatohepatitis in mice
por: Nakade, Yukiomi, et al.
Publicado: (2017)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
por: Kim, Hyeong Geug, et al.
Publicado: (2021)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k2m4qgho7idf020snevvclend4